ArticleMolecular syndromology2026
Evaluation of Cytogenetic and Molecular Genetic Tests in Patients with Short Stature.
Article in Molecular syndromology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Short stature is among the most common endocrinological diseases in childhood. The investigation of syndromic or non-syndromic genetic causes provides important data for etiology. This study aimed to present the frequency of genetic variant detection in cases in which genetic studies were performed for short stature in our clinic and the clinical characteristics of patients in whom clinically significant variants were detected. Methods: Two hundred forty-six patients who applied to our center with complaints of short stature and underwent genetic testing during a 1.5-year period were included. Anthropometric measurements, history and physical examination findings, and tests for the etiology of short stature were recorded retrospectively for all patients with pathological results. Results: Genetic tests were performed for a total of 228 children with short stature, of whom 39 (17.2%) were male and 189 (82.8%) were female. Pathogenic variants were identified in 56 (24.5%) of 228 patients. The mean height standard deviation score (SDS) of all patients was -2.63 ± 1.42. The height SDS of the patients with the gene variant was -2.73 ± 1.32. Pathological results were detected in 26 of 113 patients (23%) who underwent karyotype analysis, while clinically significant pathogenic results were obtained in 2 of 67 patients (2.9%) who underwent microarray analysis, 9 of 76 patients (30.8%) who underwent short stature panel analysis, 5 of 18 patients (27.7%) who underwent RASopathy panel testing, 7 of 37 patients (15%) who underwent SHOX MLPA, and 7 of 17 patients (6.9%) who underwent skeletal dysplasia panel analysis. Conclusion: Different genetic causes and pathophysiological processes underlie isolated and/or syndromic short stature. With the development in genetics, it is becoming easier and more important to elucidate the etiology of short stature, as in other diseases. Our study supports the significance of genetic diagnosis in patients with short stature, as it can enable diagnosis even in the absence of specific clinical findings other than short stature, and guide the necessity, efficacy, and appropriate dosing of growth hormone therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.